Provided by Tiger Trade Technology Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.58
+0.01000.64%
Post-market: 1.580.00000.00%16:04 EDT
Volume:38.44K
Turnover:61.13K
Market Cap:4.17M
PE:-0.13
High:1.63
Open:1.57
Low:1.57
Close:1.57
52wk High:14.68
52wk Low:1.29
Shares:2.64M
Float Shares:2.49M
Volume Ratio:0.67
T/O Rate:1.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.7300
EPS(LYR):-74.1816
ROE:-200.92%
ROA:-87.17%
PB:-0.68
PE(LYR):-0.02

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
Apr 24

60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website

TIPRANKS
·
Apr 15

60 Degrees Pharma partners with Runway Health to sell ARAKODA online for travelers

Reuters
·
Apr 15

60 Degrees Pharmaceuticals Inc - Pharma Announces Arakoda for Malaria Prevention Available on Runway Health Website

THOMSON REUTERS
·
Apr 15

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Apr 09

60 Degrees Pharma CEO touts tafenoquine expansion push into babesiosis in Bloomberg TV interview

Reuters
·
Apr 02

Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO)

TIPRANKS
·
Mar 31

60 Degrees Q4 EPS $(1.47) Misses $(1.12) Estimate, Sales $303.385K Miss $400.000K Estimate

Benzinga
·
Mar 31

Press Release: 60 Degrees Pharmaceuticals Announces 2025 Annual Results

Dow Jones
·
Mar 31

60 Degrees Pharma FY25 operating loss narrows 16.24% to $8.4 million

Reuters
·
Mar 31

60 Degrees Updates Affiliate Share Ownership Disclosure Error

TIPRANKS
·
Mar 21

60 Degrees Pharmaceuticals corrects affiliate beneficial ownership to 23,367 shares

Reuters
·
Mar 21

BRIEF-60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract

Reuters
·
Mar 18

60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering

TIPRANKS
·
Mar 14

What's Going On With 60 Degrees Pharmaceuticals On Friday?

Benzinga_recent_news
·
Mar 13

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM

Reuters
·
Mar 12

60 Degrees Pharmaceuticals reports 100% babesiosis cure rate in tafenoquine expanded access trial

Reuters
·
Mar 11

60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial

THOMSON REUTERS
·
Mar 11

BRIEF-60 Degrees Pharmaceuticals Company Regained Compliance With Nasdaq Minimum Bid Price

Reuters
·
Feb 12

60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status

TIPRANKS
·
Feb 12